GSK

With typical bravado, GlaxoSmithKline has, we learned on Saturday, dismissed three takeover bids from Unilever for its consumer healthcare venture with Pfizer, including one worth £50bn received just before Christmas.The drugmaker, run…

GSK says received three proposals from Unilever, but undervalued GSK to continue with spinoff of the consumer health business Unilever confirms interest, citing "strong strategic fit" Unilever, GSK under pressure from shareholders over…